Whitepapers/App Notes/Posters

Application note: From our platforms to your pen injector

Posted: 29 June 2021 | | No comments yet

Nemera offers four product platforms for pen development and manufacturing. These include reusable and disposable devices which are designed for various therapies to meet key users’ needs.

Parenteral administration has several significant advantages such as better bioavailability, faster onset of effect, more predictable pharmacokinetic and pharmacodynamic profiles and avoiding the first-pass effect.












    To read this application note in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Nemera

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Related organisations

    Send this to a friend